荟萃分析：褪黑素用于治疗原发性睡眠障碍
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders.
作者信息
Ferracioli-Oda Eduardo, Qawasmi Ahmad, Bloch Michael H
出版信息
Focus (Am Psychiatr Publ). 2018 Jan;16(1):113-118. doi: 10.1176/appi.focus.16101. Epub 2018 Jan 24.
Abstract
(Reprinted with permission from , (8)5: e63773, 2013).
摘要
（经许可重印自(8)5:e63773, 2013）
相似文献
1
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders.荟萃分析：褪黑素用于治疗原发性睡眠障碍
Focus (Am Psychiatr Publ). 2018 Jan;16(1):113-118. doi: 10.1176/appi.focus.16101. Epub 2018 Jan 24.
2
Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.外源性褪黑素治疗继发性睡眠障碍：系统评价和荟萃分析。
Front Neuroendocrinol. 2019 Jan;52:22-28. doi: 10.1016/j.yfrne.2018.06.004. Epub 2018 Jun 15.
3
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders.褪黑素治疗成人原发性睡眠障碍的疗效证据。
Sleep Med Rev. 2017 Aug;34:10-22. doi: 10.1016/j.smrv.2016.06.005. Epub 2016 Jul 20.
4
Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-Analysis.七种心理治疗干预对抑郁症患者的疗效比较：一项网状Meta分析
Focus (Am Psychiatr Publ). 2016 Apr;14(2):229-243. doi: 10.1176/appi.focus.140201. Epub 2016 Apr 7.
5
Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes.辅助性非典型抗精神病药物治疗重度抑郁症：抑郁、生活质量及安全性结局的荟萃分析
Focus (Am Psychiatr Publ). 2016 Apr;14(2):244-265. doi: 10.1176/appi.focus.140202. Epub 2016 Apr 7.
6
The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.外源性褪黑素治疗原发性睡眠障碍的疗效与安全性：一项荟萃分析。
J Gen Intern Med. 2005 Dec;20(12):1151-8. doi: 10.1111/j.1525-1497.2005.0243.x.
7
The use and misuse of exogenous melatonin in the treatment of sleep disorders.外源性褪黑素在治疗睡眠障碍中的应用与误用。
Curr Opin Pulm Med. 2018 Nov;24(6):543-548. doi: 10.1097/MCP.0000000000000522.
8
Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis.褪黑素治疗神经发育障碍儿童睡眠问题的管理：系统评价和荟萃分析。
Arch Dis Child. 2018 Dec;103(12):1155-1162. doi: 10.1136/archdischild-2017-314181. Epub 2018 May 2.
9
Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.外源性褪黑素治疗神经退行性疾病睡眠障碍：一项随机临床试验的荟萃分析
Neurol Sci. 2016 Jan;37(1):57-65. doi: 10.1007/s10072-015-2357-0. Epub 2015 Aug 9.
10
Melatonin in autism spectrum disorders: a systematic review and meta-analysis.自闭症谱系障碍中的褪黑素：系统评价和荟萃分析。
Dev Med Child Neurol. 2011 Sep;53(9):783-792. doi: 10.1111/j.1469-8749.2011.03980.x. Epub 2011 Apr 19.
引用本文的文献
1
Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or Inflammation Outcomes in Individuals with Overweight or Obesity.常用剂量的蒙特莫伦西酸樱桃粉并不能改善超重或肥胖个体的睡眠或炎症指标。
Nutrients. 2024 Nov 28;16(23):4125. doi: 10.3390/nu16234125.
2
Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.褪黑素会成为“下一个维生素 D”吗？：新兴科学、临床应用、安全性和膳食补充剂的综述。
Nutrients. 2022 Sep 22;14(19):3934. doi: 10.3390/nu14193934.
3
Trajectories of Insomnia Symptoms Among Aging Employees and Their Associations With Memory, Learning Ability, and Concentration After Retirement - A Prospective Cohort Study (2000-2017).老龄化员工失眠症状的轨迹及其与退休后记忆力、学习能力和注意力的关系：一项前瞻性队列研究（2000-2017 年）。
J Aging Health. 2022 Oct;34(6-8):916-928. doi: 10.1177/08982643221078740. Epub 2022 Apr 28.
4
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.褪黑素作为帕金森病中的一种时间生物学剂和细胞保护剂
Front Pharmacol. 2021 Apr 15;12:650597. doi: 10.3389/fphar.2021.650597. eCollection 2021.
5
Safety and Efficacy of Oral Melatonin When Combined with Thoracic Epidural Analgesia in Patients with Bilateral Multiple Fracture Ribs.口服褪黑素联合胸段硬膜外镇痛用于双侧多发性肋骨骨折患者的安全性和有效性
Local Reg Anesth. 2020 Apr 14;13:21-28. doi: 10.2147/LRA.S244510. eCollection 2020.
Zotero 插件